312 related articles for article (PubMed ID: 19546764)
21. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
[TBL] [Abstract][Full Text] [Related]
22. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer?
Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T
Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616
[TBL] [Abstract][Full Text] [Related]
23. Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy?
Smith AL; Frumovitz M; Schmeler KM; dos Reis R; Nick AM; Coleman RL; Ramirez PT
Gynecol Oncol; 2010 Nov; 119(2):183-6. PubMed ID: 20708227
[TBL] [Abstract][Full Text] [Related]
24. Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement.
Gemer O; Eitan R; Gdalevich M; Mamanov A; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Ben Shachar I; Ben Arie A; Lavie O
Eur J Surg Oncol; 2013 Jan; 39(1):76-80. PubMed ID: 23131429
[TBL] [Abstract][Full Text] [Related]
25. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
26. A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Jul; 126(1):82-6. PubMed ID: 22516661
[TBL] [Abstract][Full Text] [Related]
27. A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report.
Billingsley CC; Kohler MF; Creasman WT; Madory JE; Young JL
J Low Genit Tract Dis; 2012 Apr; 16(2):145-8. PubMed ID: 22227838
[TBL] [Abstract][Full Text] [Related]
28. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
29. Preoperative Conization and Risk of Recurrence in Patients Undergoing Laparoscopic Radical Hysterectomy for Early Stage Cervical Cancer: A Multicenter Study.
Casarin J; Bogani G; Papadia A; Ditto A; Pinelli C; Garzon S; Donadello N; Laganà AS; Cromi A; Mueller M; Raspagliesi F; Ghezzi F
J Minim Invasive Gynecol; 2021 Jan; 28(1):117-123. PubMed ID: 32320800
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.
Gemer O; Lavie O; Gdalevich M; Eitan R; Mamanov E; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Meirovitz A; Shachar IB; Arie AB
Am J Clin Oncol; 2016 Feb; 39(1):37-42. PubMed ID: 25734407
[TBL] [Abstract][Full Text] [Related]
31. Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
Matsuo K; Shimada M; Nakamura K; Takei Y; Ushijima K; Sumi T; Ohara T; Yahata H; Mikami M; Sugiyama T
Eur J Surg Oncol; 2019 Aug; 45(8):1417-1424. PubMed ID: 30846298
[TBL] [Abstract][Full Text] [Related]
32. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
33. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
[TBL] [Abstract][Full Text] [Related]
34. Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes.
Cai J; He X; Wang H; Dong W; Zhang Y; Zhao J; Willborn KC; Huang B; Wang Z; Jiang P
Radiat Oncol; 2021 Mar; 16(1):54. PubMed ID: 33743714
[TBL] [Abstract][Full Text] [Related]
35. Less radical surgery than radical hysterectomy in early stage cervical cancer: a pilot study.
Pluta M; Rob L; Charvat M; Chmel R; Halaska M; Skapa P; Robova H
Gynecol Oncol; 2009 May; 113(2):181-4. PubMed ID: 19264352
[TBL] [Abstract][Full Text] [Related]
36. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.
Ramirez PT; Frumovitz M; Pareja R; Lopez A; Vieira M; Ribeiro R; Buda A; Yan X; Shuzhong Y; Chetty N; Isla D; Tamura M; Zhu T; Robledo KP; Gebski V; Asher R; Behan V; Nicklin JL; Coleman RL; Obermair A
N Engl J Med; 2018 Nov; 379(20):1895-1904. PubMed ID: 30380365
[TBL] [Abstract][Full Text] [Related]
37. Can radical parametrectomy be omitted in occult cervical cancer after extrafascial hysterectomy?
Lu HW; Li J; Liu YY; Liu CH; Xu GC; Xie LL; Wu MF; Lin ZQ
Chin J Cancer; 2015 Aug; 34(9):413-9. PubMed ID: 26253113
[TBL] [Abstract][Full Text] [Related]
38. Surgical-pathologic risk factors and immunohistochemical markers of pelvic lymph node metastasis in stage IB1 cervical cancer.
Hernandez E; De La Mota J; Thomas MB; Huang Y; Gaughan JP; Wang F
J Low Genit Tract Dis; 2011 Oct; 15(4):303-8. PubMed ID: 21811179
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
40. Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer.
Yang Q; Zhou Q; He X; Cai J; Sun S; Huang B; Wang Z
J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102145. PubMed ID: 33848645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
